• Explore /
  • Poster
  • / Efficacy and safety of pegylated human IL-10 (AM0010) in combination with an anti-PD-1 in renal cell cancer.

Efficacy and safety of pegylated human IL-10 (AM0010) in combination with an anti-PD-1 in renal cell cancer.

Abstract Poster

Authors

null

Aung Naing

Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX

Aung Naing , Jeffrey R. Infante , Deborah Jean Lee Wong , Wolfgang Michael Korn , Raid Aljumaily , Kyriakos P. Papadopoulos , Karen A. Autio , Shubham Pant , Todd Michael Bauer , Alexandra Drakaki , Naval Guastad Daver , Annie Hung , Peter Van Vlasselaer , Gail Linda Brown , Martin Oft , Nizar M. Tannir

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT02009449

Citation

J Clin Oncol 35, 2017 (suppl; abstr 4567)

DOI

10.1200/JCO.2017.35.15_suppl.4567

Abstract #

4567

Poster Bd #

245

Abstract Disclosures

Similar Posters

First Author: Aung Naing

First Author: Deborah Jean Lee Wong

Poster

2016 ASCO Annual Meeting

Clinical activity and safety of pegylated human IL-10 (AM0010) in combination with anti-PD1.

Clinical activity and safety of pegylated human IL-10 (AM0010) in combination with anti-PD1.

First Author: Aung Naing

First Author: Shubham Pant